Youssef et al., 2024 - Google Patents
Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populationsYoussef et al., 2024
View HTML- Document ID
- 13414415152456109204
- Author
- Youssef K
- Narwade N
- Arcas A
- Marquez-Galera A
- Jiménez-Castaño R
- Lopez-Blau C
- Fazilaty H
- García-Gutierrez D
- Cano A
- Galcerán J
- Moreno-Bueno G
- Lopez-Atalaya J
- Nieto M
- Publication year
- Publication venue
- Nature Cancer
External Links
Snippet
Epithelial-to-mesenchymal transition (EMT) triggers cell plasticity in embryonic development, adult injured tissues and cancer. Combining the analysis of EMT in cell lines, embryonic neural crest and mouse models of renal fibrosis and breast cancer, we find that there is not a …
- 230000007705 epithelial mesenchymal transition 0 title abstract description 176
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Castellan et al. | Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in glioblastoma | |
Goveia et al. | An integrated gene expression landscape profiling approach to identify lung tumor endothelial cell heterogeneity and angiogenic candidates | |
Bach et al. | Differentiation dynamics of mammary epithelial cells revealed by single-cell RNA sequencing | |
Nishina et al. | Interleukin-11-expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer | |
Tabib et al. | Myofibroblast transcriptome indicates SFRP 2hi fibroblast progenitors in systemic sclerosis skin | |
Wuidart et al. | Early lineage segregation of multipotent embryonic mammary gland progenitors | |
Fazilaty et al. | A gene regulatory network to control EMT programs in development and disease | |
Nagai et al. | Downregulation of ERG and FLI1 expression in endothelial cells triggers endothelial-to-mesenchymal transition | |
Blaas et al. | Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours | |
Turpin et al. | The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment | |
Zuo et al. | MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ | |
Kujuro et al. | Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells | |
Li et al. | Core transcription regulatory circuitry orchestrates corneal epithelial homeostasis | |
Geng et al. | Comprehensive expression of Wnt signaling pathway genes during development and maturation of the mouse cochlea | |
Ben-Yair et al. | H3K27me3-mediated silencing of structural genes is required for zebrafish heart regeneration | |
Sun et al. | RETRACTED ARTICLE: Long Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression via Targeting Tumor Suppressor MicroRNAs | |
Kyjacova et al. | IER2-induced senescence drives melanoma invasion through osteopontin | |
Youssef et al. | Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations | |
Cheng et al. | Single-cell analysis reveals urothelial cell heterogeneity and regenerative cues following cyclophosphamide-induced bladder injury | |
Beermann et al. | A large shRNA library approach identifies lncRNA Ntep as an essential regulator of cell proliferation | |
Zhang et al. | Identification of differentially expressed circular RNAs in keloid and normal skin tissue by high‐throughput sequencing | |
Lyu et al. | Common and divergent gene regulatory networks control injury-induced and developmental neurogenesis in zebrafish retina | |
Li et al. | Single‐cell transcriptomes of mouse bladder urothelium uncover novel cell type markers and urothelial differentiation characteristics | |
Johnson et al. | Autophagic state prospectively identifies facultative stem cells in the intestinal epithelium | |
Groman-Lupa et al. | The transcription factor Prdm16 marks a single retinal ganglion cell subtype in the mouse retina |